ArticleDiabetology & metabolic syndrome2025
Diabetes status, duration and risk of dementia in patients with myocardial infarction.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study examines how diabetes mellitus (DM), specifically its diagnostic status and duration, influences dementia risk in individuals with a history of myocardial infarction (MI). We evaluated whether DM correlates with an increased incidence of all-cause dementia, as well as Alzheimer's disease (AD) and vascular dementia (VaD).
methodsUtilizing from the Korean National Health Insurance Database (K-NHID), this retrospective cohort study included 43,561 patients with a history of MI but no prior dementia diagnosis, tracked from 2009 to 2018. Glycemic status was categorized into normoglycemia, impaired fasting glucose (IFG), new-onset DM, and established DM of durations < 5 and ≥ 5 years. The primary outcome was all-cause dementia.
resultsDuring the median follow-up of 7.6 years, the incidence of dementia was 10.1%. Patients with established DM (≥ 5 years) exhibited a significantly higher risk of developing all-cause dementia compared to those with normoglycemia. The findings were consistent in both AD and VaD. Subgroup analyses revealed that younger patients (< 65 years) faced an even greater risk of dementia.
conclusionsWe found a significant association between the duration of DM and an elevated risk of all-cause dementia, along with AD and VaD in post-MI patients. Our findings highlight the importance of diabetes management in preserving brain health among patients with a history of myocardial infarction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.